恰加斯病的脉管系统。
The vasculature in chagas disease.
机构信息
Department of Pathology, Laboratory of Cellular and Molecular Cardiology, University of São Paulo, Ribeirão Preto, Brazil.
出版信息
Adv Parasitol. 2011;76:83-99. doi: 10.1016/B978-0-12-385895-5.00004-9.
Abstract
The cardiovascular manifestations of Chagas disease are well known. However, the contribution of the vasculature and specifically the microvasculature has received little attention. This chapter reviews the evidence supporting the notion that alterations in the microvasculature especially in the heart contribute to the pathogenesis of chagasic cardiomyopathy. These data may also be important in understanding the contributions of the microvasculature in the aetiologies of other cardiomyopathies. The role of endothelin-1 and of thromboxane A(2) vascular spasm and platelet aggregation is also discussed. Further, these observations may provide target(s) for intervention.
摘要
Chagas 病的心血管表现众所周知。然而，脉管系统，尤其是微血管的作用却很少受到关注。本章综述了微血管改变，尤其是心脏微血管改变在克山病性心肌病发病机制中的作用的相关证据。这些数据可能对理解微血管在其他心肌病发病机制中的作用也很重要。还讨论了内皮素-1 和血栓烷 A2 血管痉挛和血小板聚集的作用。此外，这些观察结果可能为干预提供靶点。
相似文献
1
The vasculature in chagas disease.恰加斯病的脉管系统。
Adv Parasitol. 2011;76:83-99. doi: 10.1016/B978-0-12-385895-5.00004-9.
2
The role of endothelin in the pathogenesis of Chagas' disease.内皮素在恰加斯病发病机制中的作用。
Int J Parasitol. 2001 May 1;31(5-6):499-511. doi: 10.1016/s0020-7519(01)00168-0.
3
Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.改善生物标志物和成像分析，以描述慢性恰加斯心肌病小鼠模型中进行性心肌纤维化。
J Am Heart Assoc. 2019 Nov 19;8(22):e013365. doi: 10.1161/JAHA.119.013365. Epub 2019 Nov 13.
4
Role of cardiac myocyte-derived endothelin-1 in chagasic cardiomyopathy: molecular genetic evidence.心肌细胞源性内皮素-1在恰加斯病性心肌病中的作用：分子遗传学证据
Clin Sci (Lond). 2002 Aug;103 Suppl 48:263S-266S. doi: 10.1042/CS103S263S.
5
Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy.恰加斯病中血小板黏附和聚集增强：心肌病的一种潜在致病机制。
Am J Trop Med Hyg. 1990 Sep;43(3):274-81. doi: 10.4269/ajtmh.1990.43.274.
6
Chagas' heart disease: clinical-pathological correlation.
Front Biosci. 2003 Jan 1;8:e94-109. doi: 10.2741/948.
7
Cardiopathogenic mediators generated by GATA4 signaling upon co-activation with endothelin-1 and Trypanosoma cruzi infection.在与内皮素-1共同激活及克氏锥虫感染时，由GATA4信号产生的心脏致病介质。
Microb Pathog. 2014 Aug;73:47-52. doi: 10.1016/j.micpath.2014.06.001. Epub 2014 Jun 11.
8
Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease.磷酰胺素对小鼠恰加斯病心肌结构和功能的心脏保护作用。
Int J Parasitol. 2002 Nov;32(12):1497-506. doi: 10.1016/s0020-7519(02)00136-4.
9
Pathophysiological insights into the cardiomyopathy of Chagas' disease.
Circulation. 1990 Dec;82(6):1900-9. doi: 10.1161/01.cir.82.6.1900.
10
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).克氏锥虫所致心脏病（恰加斯病）的研究视角
Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39. doi: 10.1016/j.pcad.2009.02.001.
引用本文的文献
1
Beyond cardiac embolism and cryptogenic stroke: unveiling the mechanisms of cerebrovascular events in Chagas disease.超越心脏栓塞和隐源性卒中：揭示恰加斯病脑血管事件的机制
Lancet Reg Health Am. 2025 Aug 8;50:101203. doi: 10.1016/j.lana.2025.101203. eCollection 2025 Oct.
2
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023.巴西心脏病学会2023年恰加斯病心肌病患者诊断与治疗指南
Arq Bras Cardiol. 2023 Jun 26;120(6):e20230269. doi: 10.36660/abc.20230269.
3
Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure.恰加斯心脏病：超越单一并发症，从无症状疾病到心力衰竭
J Clin Med. 2022 Dec 7;11(24):7262. doi: 10.3390/jcm11247262.
4
Sheltered in Stromal Tissue Cells, Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway.隐匿于基质组织细胞中，通过激活肥大细胞糜蛋白酶途径调控炎性新血管生成。
Pathogens. 2022 Jan 29;11(2):187. doi: 10.3390/pathogens11020187.
5
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?自身免疫在慢性恰加斯病相关血管炎的免疫发病机制中起作用吗？
Front Cell Infect Microbiol. 2021 Jul 6;11:671962. doi: 10.3389/fcimb.2021.671962. eCollection 2021.
6
Clinical and epidemiological aspects of chronic Chagas disease from Southern Brazil.巴西南部慢性恰加斯病的临床和流行病学方面。
Rev Soc Bras Med Trop. 2020 Oct 21;53:e20200225. doi: 10.1590/0037-8682-0225-2020. eCollection 2020.
7
Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease.慢性恰加斯病中血小板功能和频率受损及组织重塑。
PLoS One. 2019 Jun 14;14(6):e0218260. doi: 10.1371/journal.pone.0218260. eCollection 2019.
8
Low-Level Parasite Persistence Drives Vasculitis and Myositis in Skeletal Muscle of Mice Chronically Infected with Trypanosoma cruzi.低水平寄生虫持续存在可导致慢性感染克氏锥虫的小鼠骨骼肌发生血管炎和肌炎。
Infect Immun. 2019 May 21;87(6). doi: 10.1128/IAI.00081-19. Print 2019 Jun.
9
Endothelins in inflammatory neurological diseases.炎症性神经疾病中的内皮素。
Pharmacol Ther. 2019 Feb;194:145-160. doi: 10.1016/j.pharmthera.2018.10.001. Epub 2018 Oct 3.
10
Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control.锥虫感染中的炎症性和促消退脂质：理解寄生虫控制的关键
Front Microbiol. 2018 Aug 21;9:1961. doi: 10.3389/fmicb.2018.01961. eCollection 2018.
本文引用的文献
1
Parasitic diseases of the heart I: Acute and chronic Chagas' disease.心脏寄生虫病I：急性和慢性恰加斯病。
Cardiovasc Pathol. 1992 Jan-Mar;1(1):7-15. doi: 10.1016/1054-8807(92)90004-8.
2
Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.阿司匹林治疗感染克氏锥虫的小鼠及其对恰加斯病发病机制的影响。
PLoS One. 2011 Feb 15;6(2):e16959. doi: 10.1371/journal.pone.0016959.
3
Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs.低剂量辛伐他汀治疗改善克氏锥虫感染犬的心脏炎症重构。
Am J Trop Med Hyg. 2011 Feb;84(2):325-31. doi: 10.4269/ajtmh.2011.10-0451.
4
Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo.gp85/转涎酸酶在克氏锥虫组织嗜性中的作用：体内保守肽基序与脉管系统的优先结合。
PLoS Negl Trop Dis. 2010 Nov 2;4(11):e864. doi: 10.1371/journal.pntd.0000864.
5
Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.慢性恰加斯心肌病中的冠状动脉微血管疾病，包括历史、病理学和其他提出的发病机制概述。
PLoS Negl Trop Dis. 2010 Aug 31;4(8):e674. doi: 10.1371/journal.pntd.0000674.
6
Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.环核苷酸和丝裂原活化蛋白激酶：辛伐他汀对血小板激活的调节。
J Biomed Sci. 2010 Jun 4;17(1):45. doi: 10.1186/1423-0127-17-45.
7
Advances in eicosanoid research, novel therapeutic implications.二十烷酸类研究进展，新的治疗意义。
Biochem Biophys Res Commun. 2010 May 21;396(1):135-9. doi: 10.1016/j.bbrc.2010.03.140.
8
Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.阿托伐他汀改善扩张型心肌病患者的内皮功能和心功能：炎症的作用。
Cardiovasc Drugs Ther. 2009 Oct;23(5):369-76. doi: 10.1007/s10557-009-6186-3.
9
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease).克氏锥虫所致心脏病（恰加斯病）的研究视角
Prog Cardiovasc Dis. 2009 May-Jun;51(6):524-39. doi: 10.1016/j.pcad.2009.02.001.
10
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection.血栓素A2是克氏锥虫感染期间发病机制的关键调节因子。
J Exp Med. 2007 Apr 16;204(4):929-40. doi: 10.1084/jem.20062432. Epub 2007 Apr 9.
Zotero 插件